Waterstone is an international pharmaceutical company with its main operations in 

China. The company is focused in discovery, development and commercialization of 

innovative drugs for the treatment of liver and gastrointestinal diseases. With 

venture capital investments from internationally well-known firms such as BAR 

Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully 

integrated capabilities from R&D, API & Finished Drug Product manufacturing to 

sales/marketing. The company has a strong management team with cross-border 

experience and advisors with expertise in drug discovery, regulatory, and GMP 

manufacturing. On top of the forty marked drugs in China, the company has also 

built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase 

II/III clinical tries with cFDA, and several novel preclinical stage antiviral and 

oncology candidates



Waterstone is an international bio-pharmaceutical company committed to the discovery, development and commercilization of therapeutics for significant unmet medical needs

Mobile Scan´╝îLearn more
About
Company Profile
Management Team
Board of Directors
Vision & Mission
Corporate History
Pipeline
Liver Diseases
Oncology
ANDA
Products
Marketing
Sales Network
Other Drug Products
API (DMFs)
Lansoprizoe
Gensicilovir Sodium
Febuxostat
Investors
BAR Capital
Acorn Campus Ventures
CID Group
Orbimed
News
Company News
Media Reports
Publications
Contacts
Location & massage
Career